[Cardiopulmonary complications in sickle cell anemia].
Sickle cell anemia, considered the most prevalent genetic disease among African Americans, is a disease with autosomal recessive inheritance pattern, characterized by the production of hemoglobin S. This abnormal protein polymerizes and facilitates the formation of fibrillar aggregates that alters the erythrocyte morphology. The stiffness of the red blood cells hinders the adequate transit across microcirculation, leading to hemolysis and increased blood viscosity, which ease thrombogenesis and vascular occlusion, resulting in tissue ischemia and microinfarcts. This disease has a high rate of morbidity and mortality, especially in the first three years of life, when a rapid diagnosis and appropriate treatment are essential. Cardiovascular complications such as heart failure and pulmonary hypertension may develop independently, and each one contributes to increased mortality, being the combination of both risk factors, an important aggravating factor for prognosis and a determinant indicator of mortality.
Facultad de Medicina, Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana, Medellín, Colombia. Electronic address: sararojasji@gmail.com.
Sara
S
Rojas-Jiménez
Facultad de Medicina, Escuela de Ciencias de la Salud, Universidad Pontificia Bolivariana, Medellín, Colombia.
Johan
J
Lopera-Valle
Servicio de Cardiología Pediátrica y Ecocardiografía, Hospital Pablo Tobón Uribe, Medellín, Colombia.
Mirna
M
Yabur-Espítia
D000755:Anemia, Sickle Cell / Q000150:complications*; D006331:Heart Diseases / Q000209:etiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D008171:Lung Diseases / Q000209:etiology*
Anemia Sickle Cell; Anemia de células falciformes; Colombia; Heart Failure; Hipertensión pulmonar; Hypertension Pulmonary; Insuficiencia cardíaca